Logo
x

Search

Subscribe Now

Amends

Moderna Amends its Agreement with UK Government for an Additional 2M Doses of COVID-19 Vaccine

Moderna Amends its Agreement with UK Government for an Additional 2M Doses of COVID-19 Vaccine

  • November 30, 2020
Eli Lilly Amends its 2013 Agreement with Chi-Med to Commercialize Elunate (fruquintinib) in China

Eli Lilly Amends its 2013 Agreement with Chi-Med to Commercialize Elunate (fruquintinib) in China

  • July 28, 2020
Thermo Fisher Scientific Amends its Agreement to Acquire QIAGEN

Thermo Fisher Scientific Amends its Agreement to Acquire QIAGEN

  • July 17, 2020
Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018

Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018

  • November 8, 2019
AstraZeneca Amends its Development and Commercialization Agreement with Ironwood for Linzess (linaclotide) Signed in 2012

AstraZeneca Amends its Development and Commercialization Agreement with Ironwood for Linzess (linaclotide) Signed in 2012

  • September 18, 2019
GSK Amends its Development and Commercialization Agreement with Liquidia for Inhaled Therapies

GSK Amends its Development and Commercialization Agreement with Liquidia for Inhaled Therapies

  • June 27, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.